Efficacy and Safety of Dual Paclitaxel and Sirolimus Nanoparticle-Coated Balloon.

A similar assessment for the media showed a statistical trend toward a greater percentage of BrdU-positive nuclei in the dual API DCB than in the PTX DCB (median [Q1-Q3]: 24.3 [20.9-26.7] vs 18.7 [9.8-23.2]; P = 0.092) ( Figure 2F ), whereas there was no statistical difference between the dual API DCB and the PTX DCB in the number of nuclei (median [Q1-Q3]: 1,095.3 [790.7-1285.2] vs 1,061.7 [596.0-1256.2]; P = 0.67) ( Figure 2D ) and the number of BrdU-positive nuclei (median [Q1-Q3]: 238.0 [187.8-312.2] vs 221.3 [63.7-241.7]; P = 0.35) ( Figure 2E ).

also in 1,033 other papers